Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

KFDA Clearance for StoneChecker Software

20 Jan 2020 07:00

RNS Number : 2389A
IQ-AI Limited
20 January 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

IQ-AI Announce Korean FDA Clearance to Market for StoneChecker Software, and GMP certification for Imaging Biometrics, and the appointment of Dr Balaji Ganeshan as consultant

 

IQ-AI has received notification that the Korean FDA (KFDA) has cleared StoneChecker Software for marketing in the Republic of Korea, a key market for high-tech medical imaging hardware and software. In addition, Imaging Biometrics (IB) has received GMP certification.

 

Trevor Brown, Chief Executive of IQ-AI commented, "We are delighted that StoneChecker Software has received KFDA approval for marketing in the Republic of Korea, our Korean distributor's marketing plans can now be fully implemented. It also gives me great pleasure to welcome back Dr Balaji Ganeshan to the team. Dr Ganeshan, an exceptionally innovative medical imaging entrepreneur and scientist, has invaluable expertise and ideas in a number of key technologies relevant to the Company. He will be working as a consultant for IB."

 

Dr Ganeshan, who was previously a director of StoneChecker Software, holds the position of Senior Research Associate at the Institute of Nuclear Medicine at University College London and is a prolific academic scientist in the area of medical image analysis. 

 

Dr. Balaji Ganeshan commented, "I very much look forward to working alongside Trevor Brown again, and also the team at IB, on all the technologies that IQ-AI have access to."

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Michael Schmainda

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRSFFFAUESSEEF
Date   Source Headline
16th Jun 20177:00 amRNSReadmission to the London Stock Exchange
15th Jun 20171:42 pmRNSResult of Annual General Meeting & General Meeting
19th May 20177:00 amRNSProspectus, Placing & Expected Readmission
28th Apr 20173:12 pmRNSFinal Results
27th Feb 201711:51 amRNSHolding(s) in Company
20th Jan 20171:30 pmRNSAppointment of Non-Executive Director
26th Aug 201612:06 pmRNSHalf-year Report
30th Jun 201612:58 pmRNSProposed Acquisition and Suspension of Listing
31st May 20161:33 pmRNSHolding(s) in Company
27th May 201611:39 amRNSResult of AGM
5th May 20164:15 pmRNSHolding(s) in Company
4th May 20167:00 amRNSNotice of AGM
20th Apr 20167:00 amRNSHolding(s) in Company
20th Apr 20167:00 amRNSFinal Results
5th Apr 201610:48 amRNSStatement re Update
20th Nov 20157:00 amRNSBoard changes, corporate update, issue of CLN
21st Oct 20157:00 amRNSAppointment of Financial Adviser and Broker
25th Aug 20153:29 pmRNSHalf Yearly Report
16th Jul 201511:17 amRNSHolding(s) in Company
16th Jul 201511:15 amRNSHolding(s) in Company
13th Jul 20152:57 pmRNSConversion of Convertible Loan Notes
29th May 20154:21 pmRNSResult of AGM
1st May 201511:28 amRNSNotice of AGM and Transfer of CLN to Director-Rep
30th Apr 20156:28 pmRNSNotice of AGM and Transfer of CLN to Director
17th Apr 201511:00 amRNSPreliminary Results
11th Mar 20152:16 pmRNSResult of EGM
13th Feb 20157:00 amRNSBoard Changes and Notice of EGM
31st Dec 20147:00 amRNSUpdate
7th Nov 20143:24 pmRNSSale of Retreat Farm
27th Aug 20147:00 amRNSInterim Results Announcement
11th Jun 201411:42 amRNSResult of AGM
29th Apr 20143:33 pmRNSAnnual Report and Results Announcement
8th Apr 20147:00 amRNSDirectorate Change
9th Jan 201411:30 amRNSDirectorate Change
15th Nov 20137:00 amRNSInterim Management Statement
28th Aug 20137:00 amRNSHalf Yearly Report
13th Jun 20137:00 amRNSResult of AGM
26th Apr 20137:00 amRNSAnnual Report and Results Announcement
25th Apr 20134:59 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jan 20131:31 pmRNSRefinancing of Flowers Direct and Board changes
19th Nov 20127:00 amRNSTrading Update
31st Aug 20127:00 amRNSHalf Yearly Report
1st Aug 20127:00 amRNSClosure of Growing and Live Dispatch Business
9th Jul 20127:00 amRNSDisposal
13th Jun 201210:25 amRNSResult of AGM
6th Jun 20128:05 amRNSTransfer to Standard Listing
28th May 20123:03 pmRNSMerger Update
22nd May 201211:15 amRNSInterim Management Statement
16th May 20122:00 pmRNSMerger Update
4th May 201210:27 amRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.